Navigation Links
Othera Pharmaceuticals Announces Upcoming Presentation Based Upon,Expanded Understanding of Lead Compound Mechanism of Action

EXTON, Pa.--(BUSINESS WIRE)--Apr 19, 2007 - Othera Pharmaceuticals, Inc. today announced that Dr. Shaker Mousa, Professor of Pharmacology and Executive Vice President and Chairman of the Pharmaceutical Research Institute at Albany College of Pharmacy, will present new preclinical data detailing the observed antithrombotic effect of Othera's lead compound, OT-551, and related Othera compounds. This work stems from previous ocular studies on OT-551 eye drops, as well as studies on novel, orally-available analog compounds under development for non-ophthalmic indications. Dr. Mousa's talk will be presented at the XXI International Society on Thrombosis and Haemostasis (ISTH) Congress in Geneva, Switzerland on July 9, 2007. The ISTH holds its congress every other year and the organization includes 2,800 thrombosis, hemostasis and vascular biology researchers and clinicians from more than 70 countries.

In his abstract, Dr. Mousa describes how OT-551 operates within the cell to downregulate Nuclear Factor kappa B (NF-kB), a transcription factor whose overexpression is associated with a host of inflammation-related ocular and non-ocular diseases. In combination with OT-551's previously known antioxidant and antiangiogenic activities, elucidation of this new mechanism provides strong support for the ophthalmic indications that Othera is currently pursuing with OT-551, as well as new non-ophthalmic indications for analogous oral compounds. Specific diseases of interest to Othera that have been linked to NF-kB overactivity in the scientific literature include age-related macular degeneration (AMD), cataracts, dry eye, resistance to cancer chemotherapy, cancer-related thrombosis and rheumatoid arthritis.

A New Understanding of How OT-551 Works in Ocular Disease

In conjunction with Othera scientists, Dr. Mousa performed large-scale gene expression studies using microchip arrays that provided evidence of OT-551
'"/>




Page: 1 2 3 4

Related medicine technology :

1. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
2. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
4. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
5. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
6. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
7. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
8. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
9. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
10. Cyclacel Pharmaceuticals Announces Results of Phase II Seliciclib Combination Studies
11. Arisaph Pharmaceuticals Announces Results of its Potent Smart DPP-4 Inhibitor, ARI-2243, at the ADA
Post Your Comments:
(Date:9/2/2015)... About Duchenne muscular dystrophy Duchenne ... affects the male population. It is characterized by ... caused due to mutations in the dystrophin gene, ... dystrophin (a protein essential for maintaining healthy muscle ... muscle function, causes loss of ambulation, harms the ...
(Date:9/2/2015)... -- About Chronic Lymphocytic Leukemia Chronic ... production of lymphocytes. It has been observed that the ... to other parts of the body. This leukemia is ... buildup of the cancerous cells. During the course of ... and lymph nodes. The course of the disease is ...
(Date:9/2/2015)... DUBLIN , Sept. 2, 2015 Research and ... "Pharmaceutical Regulatory Affairs in China (Basel, Switzerland - November ... This seminar will provide a detailed overview of the key ... , Hong Kong , Macau ... cover: - All important aspects of gaining ...
Breaking Medicine Technology:Global Duchenne Muscular Dystrophy Drugs Market 2015-2019 2Global Duchenne Muscular Dystrophy Drugs Market 2015-2019 3Global Chronic Lymphocytic Leukemia Therapeutics Market 2015-2019 2Global Chronic Lymphocytic Leukemia Therapeutics Market 2015-2019 3Pharmaceutical Regulatory Affairs in China Seminar: Basel, Switzerland - November 26-27, 2015 2
... FRANCISCO, Oct. 14 Medizone International, Inc. ... round of AsepticSure(TM) trials have begun at Innovation Park, ... the first and second round of laboratory testing, this ... protocols necessary in order to obtain maximum bactericidal action ...
... Oct. 14 Cardiva Medical, Inc. announces today that its ... position of Chief Executive Officer at Innovative Energy, Inc., an ... of Cardiva Medical stated, "I would like to thank Glenn ... During his tenure as President, we have transformed Cardiva ...
Cached Medicine Technology:Medizone International Announces Third Round of AsepticSure 2Cardiva Medical, Inc. Announces the Departure of its President and his Appointment as CEO of Innovative Energy, Inc. 2Cardiva Medical, Inc. Announces the Departure of its President and his Appointment as CEO of Innovative Energy, Inc. 3
(Date:9/3/2015)... ... September 03, 2015 , ... ProScrub is a set of automated ... flicker, repeat, and custom speed effects without the use of keyframes. Utilize ProScrub's ... ProScrub tools are perfect complements to energetic video productions. ProScrub is a ...
(Date:9/3/2015)... ... 03, 2015 , ... A scar is an unavoidable result of incision or injury to the ... ability to heal itself. The appearance of a scar is dependent on many factors – ... skin pigmentation. ”Many scars fade to near invisibility on their own over a period of ...
(Date:9/3/2015)... Los Angeles, CA (PRWEB) , ... September 03, 2015 , ... ... on iTunes , Google Play , and Amazon and will ... Sherr, the lead from “My Darling is a Foreigner,” Itsuka, an actress and singer/songwriter, ...
(Date:9/3/2015)... ... September 03, 2015 , ... Representatives with State ... the highly anticipated Mississippi Gulf Babypalooza on September 19, 2015. , “We will ... Gulfport, Biloxi, and beyond. We will be discussing setting up college funds, offering ...
(Date:9/3/2015)... (PRWEB) , ... September 03, 2015 , ... At Renew ... becoming dissatisfied with the traditional health care model, where the primary care physician dictates ... individuals who want to become educated about their health issues and empowered to choose ...
Breaking Medicine News(10 mins):Health News:FCPX Effects Developer Releases ProScrub for Final Cut Pro X 2Health News:Do I Have To Live With That Scar? 2Health News:Do I Have To Live With That Scar? 3Health News:Do I Have To Live With That Scar? 4Health News:The Romantic Comedy Film "Love in Tokyo" Has Been Released on ITunes, Google Play, and Amazon 2Health News:State Farm Agent EJ Roberts to Help Expecting Mothers at the Mississippi Gulf Babypalooza 2Health News:Men Dissatisfied with the Primary Care Physician’s Approach to Andropause Are Turning to Renew Man™ 2Health News:Men Dissatisfied with the Primary Care Physician’s Approach to Andropause Are Turning to Renew Man™ 3
... BROOK, Ill. Using advanced MRI and an artificial ... method that may help identify which individuals with mild ... a study published online and in the December issue ... half of all individuals with early-stage mild cognitive impairment ...
... Radiation therapy is used to treat more than half ... can vary greatly. Genetics is increasingly being recognized ... but the biology underlying response remains poorly understood. ... Research ( www.genome.org ), researchers employed a pharmacogenomics ...
... discovered biomarkers that could lead to personalized radiation treatments ... the journal Genome Research . "Overcoming ... for some individuals," says Liewei Wang, M.D., Ph.D., Mayo ... "Our findings may make it possible to one day ...
... Health, a unique benefits program for Group Health Cooperative employees, ... Agency for Health Research and Quality (AHRQ) recently funded. It,s ... programs and base them on research findings. The goal is ... Launched in January 2010 and available to all 9,000 ...
... researcher from the Faculty of Medicine & Dentistry at the ... of obesity and addictions which could lead to a treatment ... the wild, it is a rewarding stimulus for the animal ... the chemical messenger dopamine. Because narcotics such as cocaine, heroin ...
... Medical School will establish a joint institute with the ... to promote research that can lead to breakthroughs in ... joint institute will feature collaborative research efforts, exchanges of ... of large-scale clinical trials. "Our Medical School ...
Cached Medicine News:Health News:MRI may predict continued decline in patients with mild cognitive impairment 2Health News:Radiation pharmacogenomics identifies biomarkers that could personalize cancer treatment 2Health News:Incentives studied to align care, coverage and wellness 2Health News:Incentives studied to align care, coverage and wellness 3Health News:Mechanism involved in addictions and some forms of obesity discovered in U of A lab 2Health News:U-M Medical School creates joint institute with Peking University 2Health News:U-M Medical School creates joint institute with Peking University 3
Store microscope slides with ease, speed, efficiency....
... drawers for just about everything imaginable that might ... Each box is designed for long term storage ... of wood over metal systems is overlooked, while ... subtle kind of desiccator and insulator, providing an ...
A prepared Microscope Slide Cataloging and Storage System....
... resistant, plastic covered corrugated boxes interlock ... up to 500 lbs of overhead ... accommodates 2000 slides or 500 tissue ... requirements. Come unassembled boxes require minimal ...
Medicine Products: